While short-term viability assays in differentiated GBM cells showed minimal effects, likely due to cell adhesion-mediated resistance via focal adhesion kinase [26,27], clonogenic assays revealed a pronounced reduction in colony formation particularly in the MGMT-unmethylated LN18 line. The gene discussed is MGMT; the disease is glioblastoma.